Our Global Human Genome

  • Share This:

In order to create a comprehensive genomic cancer database, scientists have to reach out to the entire world. Starting with the underserved populations in South Chicago, oncologist Olufunmilayo Olopade began studying the occurrence of BRCA1 and BRCA2 genes in breast cancer around the world. It wasn’t long before she realized that the far-flung human genome will present a variety of complications and proclivities pertaining to each different cancer. Travelling as far as Nigeria for her research, Olopade stresses the need for researchers to also go out and collect the data, rather than waiting for developing countries to catch up.
More from this series: Cancer’s Last Stand

Sign up for our free newsletter to see exclusive features and be the first to get news and updates on upcoming WSF programs.


Date: Thursday June 2, 2011
Time: 08:00 PM-09:30 PM
Venue: NYU Kimmel Center, Eisner & Lubin Auditorium
Moderator: Richard Besser
Participants: Mary-Claire King, Eric Lander, Siddhartha Mukherjee, Olufunmilayo Olopade

The deadly scourge of cancer has confounded doctors since ancient Egypt. Now, The Cancer Genome Atlas (modeled after the Human Genome Project) promises a new and powerful approach in this age-old battle. We joined a discussion including Eric Lander, Mary-Claire King and other leaders in the field as they described how and why the balance of power in the war on cancer may finally be shifting. Related WSF Salon: Genetics and Cancer More from this series: Cancer's Last Stand...[Read more]